Supplemental Guarantor/Non-Guarantor Financial Information Consolidating Statement of Cash Flows (Details) (USD $) | 6 Months Ended |
In Thousands, unless otherwise specified | Jun. 30, 2014 | Jun. 30, 2013 |
Condensed Financial Statements, Captions [Line Items] | ' | ' |
Intercompany accounts payable | $0 | ' |
Cash flows from operating activities | 721,479 | 451,515 |
Additions to properties, plants and equipment | -205,987 | -153,942 |
Proceeds from sale of properties, plants, and equipment | 0 | 5,802 |
Investment in Sabine Biofuels | -5,000 | -2,000 |
Net repayment of advances to Sabine Biofuels | 10,021 | -13,700 |
Purchases of marketable securities | -498,080 | -399,154 |
Sales and maturities of marketable securities | 543,604 | 398,762 |
Net Advances to Parent | 0 | 0 |
Net cash used for investing activities | -194,224 | -181,093 |
Net borrowings under credit agreement b HEP | -180,000 | ' |
Proceeds from common unit offerings | 0 | 146,888 |
Net repayments under credit agreement b HEP | ' | 66,000 |
Redemption of Senior Notes - HEP | -156,188 | -300,973 |
Inventory repurchase obligation | 5,964 | 0 |
Purchase of treasury stock | -20,135 | -159,432 |
Contribution from General Partner | ' | 0 |
Dividends | -323,088 | -264,867 |
Excess tax benefit from equity based compensation | 3,778 | 1,037 |
Deferred financing costs and other | 433 | 2,184 |
Net advances from subsidiaries | 0 | 0 |
Net cash provided by (used for) financing activities | -349,056 | -678,701 |
Increase (decrease) for the period | 178,199 | -408,279 |
Beginning of period | 940,103 | 1,757,699 |
End of period | 1,118,302 | 1,349,420 |
Principal tender on senior notes | 0 | -300,973 |
Parent Company [Member] | ' | ' |
Condensed Financial Statements, Captions [Line Items] | ' | ' |
Intercompany accounts payable | 1,085,461 | ' |
Cash flows from operating activities | -144,972 | -374,074 |
Additions to properties, plants and equipment | -6,329 | -5,025 |
Proceeds from sale of properties, plants, and equipment | ' | 0 |
Investment in Sabine Biofuels | 0 | 0 |
Net repayment of advances to Sabine Biofuels | 0 | 0 |
Purchases of marketable securities | -498,080 | -399,154 |
Sales and maturities of marketable securities | 543,604 | 398,762 |
Net Advances to Parent | 0 | 0 |
Net cash used for investing activities | 39,195 | -5,417 |
Net borrowings under credit agreement b HEP | 0 | ' |
Redemption of Senior Notes - HEP | 0 | -300,973 |
Inventory repurchase obligation | 0 | ' |
Purchase of treasury stock | -20,135 | -159,432 |
Contribution from General Partner | ' | 0 |
Dividends | -323,088 | -264,867 |
Distributions to noncontrolling interest | 0 | 0 |
Excess tax benefit from equity based compensation | 3,778 | 1,037 |
Purchase of units for restricted grants - HEP | 0 | ' |
Deferred financing costs and other | 0 | 0 |
Net advances from subsidiaries | 621,534 | 615,078 |
Net cash provided by (used for) financing activities | 282,089 | -35,713 |
Increase (decrease) for the period | 176,312 | -415,204 |
Beginning of period | 931,920 | 1,748,808 |
End of period | 1,108,232 | 1,333,604 |
Guarantor Restricted Subsidiaries [Member] | ' | ' |
Condensed Financial Statements, Captions [Line Items] | ' | ' |
Intercompany accounts payable | 0 | ' |
Cash flows from operating activities | 773,845 | 758,289 |
Additions to properties, plants and equipment | -199,132 | -148,917 |
Proceeds from sale of properties, plants, and equipment | ' | -3,321 |
Investment in Sabine Biofuels | -5,000 | -2,000 |
Net repayment of advances to Sabine Biofuels | 10,021 | -13,700 |
Purchases of marketable securities | 0 | 0 |
Sales and maturities of marketable securities | 0 | 0 |
Net Advances to Parent | -582,930 | -596,004 |
Net cash used for investing activities | -777,041 | -757,300 |
Net borrowings under credit agreement b HEP | 0 | ' |
Proceeds from common unit offerings | ' | 0 |
Redemption of Senior Notes - HEP | 0 | 0 |
Inventory repurchase obligation | 5,964 | ' |
Purchase of treasury stock | 0 | 0 |
Contribution from General Partner | ' | 0 |
Dividends | 0 | 0 |
Distributions to noncontrolling interest | 0 | 0 |
Excess tax benefit from equity based compensation | 0 | 0 |
Purchase of units for restricted grants - HEP | 0 | ' |
Deferred financing costs and other | 808 | 2,457 |
Net advances from subsidiaries | 0 | 0 |
Net cash provided by (used for) financing activities | 5,156 | 2,457 |
Increase (decrease) for the period | 1,960 | 3,446 |
Beginning of period | 1,817 | 3,652 |
End of period | 3,777 | 7,098 |
Non Guarantor Restricted Subsidiaries [Member] | ' | ' |
Condensed Financial Statements, Captions [Line Items] | ' | ' |
Intercompany accounts payable | 0 | ' |
Cash flows from operating activities | 38,968 | 20,573 |
Additions to properties, plants and equipment | -526 | 0 |
Proceeds from sale of properties, plants, and equipment | ' | 0 |
Investment in Sabine Biofuels | 0 | 0 |
Net repayment of advances to Sabine Biofuels | 0 | 0 |
Purchases of marketable securities | 0 | 0 |
Sales and maturities of marketable securities | 0 | 0 |
Net Advances to Parent | -38,604 | -19,074 |
Net cash used for investing activities | -39,130 | -19,074 |
Net borrowings under credit agreement b HEP | 0 | ' |
Proceeds from common unit offerings | ' | 0 |
Redemption of Senior Notes - HEP | 0 | 0 |
Inventory repurchase obligation | 0 | ' |
Purchase of treasury stock | 0 | 0 |
Contribution from General Partner | ' | 1,499 |
Dividends | 0 | 0 |
Distributions to noncontrolling interest | 0 | 0 |
Excess tax benefit from equity based compensation | 0 | 0 |
Purchase of units for restricted grants - HEP | 0 | ' |
Deferred financing costs and other | -375 | 0 |
Net advances from subsidiaries | 0 | 0 |
Net cash provided by (used for) financing activities | 375 | -1,499 |
Increase (decrease) for the period | 213 | 0 |
Beginning of period | 14 | 2 |
End of period | 227 | 2 |
Eliminations [Member] | ' | ' |
Condensed Financial Statements, Captions [Line Items] | ' | ' |
Intercompany accounts payable | -1,085,461 | ' |
Cash flows from operating activities | 0 | 0 |
Additions to properties, plants and equipment | 0 | 0 |
Proceeds from sale of properties, plants, and equipment | ' | 0 |
Investment in Sabine Biofuels | 0 | 0 |
Net repayment of advances to Sabine Biofuels | 0 | 0 |
Purchases of marketable securities | 0 | 0 |
Sales and maturities of marketable securities | 0 | 0 |
Net Advances to Parent | 621,534 | 615,078 |
Net cash used for investing activities | 621,534 | 615,078 |
Net borrowings under credit agreement b HEP | 0 | ' |
Proceeds from common unit offerings | ' | 0 |
Net repayments under credit agreement b HEP | ' | 0 |
Redemption of Senior Notes - HEP | 0 | 0 |
Inventory repurchase obligation | 0 | ' |
Purchase of treasury stock | 0 | 0 |
Contribution from General Partner | ' | 0 |
Dividends | 0 | 0 |
Distributions to noncontrolling interest | 0 | 0 |
Excess tax benefit from equity based compensation | 0 | 0 |
Purchase of units for restricted grants - HEP | 0 | 0 |
Deferred financing costs and other | 0 | 0 |
Net advances from subsidiaries | 621,534 | 615,078 |
Net cash provided by (used for) financing activities | -621,534 | -615,078 |
Increase (decrease) for the period | 0 | 0 |
Beginning of period | 0 | 0 |
End of period | 0 | 0 |
Holly Frontier Corp. Before Consolidation Of HEP [Member] | ' | ' |
Condensed Financial Statements, Captions [Line Items] | ' | ' |
Intercompany accounts payable | 0 | ' |
Cash flows from operating activities | 667,841 | 404,788 |
Additions to properties, plants and equipment | -205,987 | -153,942 |
Proceeds from sale of properties, plants, and equipment | ' | -3,321 |
Investment in Sabine Biofuels | -5,000 | -2,000 |
Net repayment of advances to Sabine Biofuels | 10,021 | -13,700 |
Purchases of marketable securities | -498,080 | -399,154 |
Sales and maturities of marketable securities | 543,604 | 398,762 |
Net Advances to Parent | 0 | 0 |
Net cash used for investing activities | -155,442 | -166,713 |
Net borrowings under credit agreement b HEP | 0 | ' |
Proceeds from common unit offerings | ' | 73,444 |
Redemption of Senior Notes - HEP | 0 | -300,973 |
Inventory repurchase obligation | 5,964 | ' |
Purchase of treasury stock | -20,135 | -159,432 |
Contribution from General Partner | ' | 1,499 |
Dividends | -323,088 | -264,867 |
Distributions to noncontrolling interest | 0 | 0 |
Excess tax benefit from equity based compensation | 3,778 | 1,037 |
Purchase of units for restricted grants - HEP | 0 | ' |
Deferred financing costs and other | 433 | 2,457 |
Net advances from subsidiaries | 0 | 0 |
Net cash provided by (used for) financing activities | -333,914 | -649,833 |
Increase (decrease) for the period | 178,485 | -411,758 |
Beginning of period | 933,751 | 1,752,462 |
End of period | 1,112,236 | 1,340,704 |
Non-Guarantor Non-Restricted Subsidiaries (HEP Segment) [Member] | ' | ' |
Condensed Financial Statements, Captions [Line Items] | ' | ' |
Intercompany accounts payable | 0 | ' |
Cash flows from operating activities | 92,667 | 81,542 |
Additions to properties, plants and equipment | 0 | -16,861 |
Proceeds from sale of properties, plants, and equipment | ' | -2,481 |
Investment in Sabine Biofuels | 0 | 0 |
Net repayment of advances to Sabine Biofuels | 0 | 0 |
Purchases of marketable securities | 0 | 0 |
Sales and maturities of marketable securities | 0 | 0 |
Net Advances to Parent | 0 | 0 |
Net cash used for investing activities | -38,782 | -14,380 |
Net borrowings under credit agreement b HEP | -180,000 | ' |
Proceeds from common unit offerings | ' | 73,444 |
Net repayments under credit agreement b HEP | ' | 66,000 |
Redemption of Senior Notes - HEP | -156,188 | 0 |
Inventory repurchase obligation | 0 | ' |
Purchase of treasury stock | 0 | 0 |
Contribution from General Partner | ' | 1,499 |
Dividends | 0 | 0 |
Distributions to noncontrolling interest | -77,577 | -69,419 |
Excess tax benefit from equity based compensation | 0 | 0 |
Purchase of units for restricted grants - HEP | -406 | -2,934 |
Deferred financing costs and other | 0 | -273 |
Net advances from subsidiaries | 0 | 0 |
Net cash provided by (used for) financing activities | -54,171 | -63,683 |
Increase (decrease) for the period | -286 | 3,479 |
Beginning of period | 6,352 | 5,237 |
End of period | 6,066 | 8,716 |
Eliminations [Member] | ' | ' |
Condensed Financial Statements, Captions [Line Items] | ' | ' |
Intercompany accounts payable | 0 | ' |
Cash flows from operating activities | -39,029 | -34,815 |
Additions to properties, plants and equipment | 0 | 0 |
Proceeds from sale of properties, plants, and equipment | ' | 0 |
Investment in Sabine Biofuels | 0 | 0 |
Net repayment of advances to Sabine Biofuels | 0 | 0 |
Purchases of marketable securities | 0 | 0 |
Sales and maturities of marketable securities | 0 | 0 |
Net Advances to Parent | 0 | 0 |
Net cash used for investing activities | 0 | 0 |
Redemption of Senior Notes - HEP | 0 | 0 |
Inventory repurchase obligation | 0 | ' |
Purchase of treasury stock | 0 | 0 |
Contribution from General Partner | ' | 0 |
Dividends | 0 | 0 |
Distributions to noncontrolling interest | 39,029 | 34,815 |
Excess tax benefit from equity based compensation | 0 | 0 |
Purchase of units for restricted grants - HEP | 0 | 0 |
Deferred financing costs and other | 0 | 0 |
Net advances from subsidiaries | 0 | 0 |
Net cash provided by (used for) financing activities | 39,029 | 34,815 |
Increase (decrease) for the period | 0 | 0 |
Beginning of period | 0 | 0 |
End of period | 0 | 0 |
HEP [Member] | ' | ' |
Condensed Financial Statements, Captions [Line Items] | ' | ' |
Additions to properties, plants and equipment | -38,782 | -16,861 |
Proceeds from common unit offerings | ' | 73,444 |
Distributions to noncontrolling interest | -38,548 | -34,604 |
Purchase of units for restricted grants - HEP | -406 | -2,934 |
Beginning of period | 6,352 | ' |
End of period | 6,066 | ' |
Principal tender on senior notes | -156,188 | 0 |
HEP [Member] | Parent Company [Member] | ' | ' |
Condensed Financial Statements, Captions [Line Items] | ' | ' |
Additions to properties, plants and equipment | 0 | 0 |
Proceeds from common unit offerings | ' | 73,444 |
Net repayments under credit agreement b HEP | ' | 0 |
Purchase of units for restricted grants - HEP | ' | 0 |
HEP [Member] | Guarantor Restricted Subsidiaries [Member] | ' | ' |
Condensed Financial Statements, Captions [Line Items] | ' | ' |
Additions to properties, plants and equipment | 0 | 0 |
Net repayments under credit agreement b HEP | ' | 0 |
Purchase of units for restricted grants - HEP | ' | 0 |
HEP [Member] | Non Guarantor Restricted Subsidiaries [Member] | ' | ' |
Condensed Financial Statements, Captions [Line Items] | ' | ' |
Additions to properties, plants and equipment | 0 | 0 |
Net repayments under credit agreement b HEP | ' | 0 |
Purchase of units for restricted grants - HEP | ' | 0 |
HEP [Member] | Holly Frontier Corp. Before Consolidation Of HEP [Member] | ' | ' |
Condensed Financial Statements, Captions [Line Items] | ' | ' |
Additions to properties, plants and equipment | 0 | 0 |
Net repayments under credit agreement b HEP | ' | 0 |
Purchase of units for restricted grants - HEP | ' | 0 |
HEP [Member] | Eliminations [Member] | ' | ' |
Condensed Financial Statements, Captions [Line Items] | ' | ' |
Additions to properties, plants and equipment | 0 | 0 |
Net borrowings under credit agreement b HEP | 0 | ' |
Proceeds from common unit offerings | ' | 0 |
Net repayments under credit agreement b HEP | ' | $0 |